Genmab A (GMAB) Assets (2019 - 2026)

Genmab A has reported Assets for 6 years, with the latest figure at $12.4 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets fell 3.86% year-over-year to $12.4 billion; the trailing twelve-month figure through Mar 2026 stood at $12.4 billion (down 3.86% YoY), and the FY2025 full-year result was $12.9 billion, up 100.7% from the prior year.
• Assets for Q1 2026 stood at $12.4 billion, down from $12.9 billion in the prior quarter.
• The five-year high for Assets was $12.9 billion in Q1 2025, with the low at $5.2 billion in Q4 2023.
• Historically, Assets has averaged $8.7 billion across 4 years, with a median of $6.7 billion in 2025.
• Annual changes were most pronounced in 2025 — Assets surged 100.7% — and 2026, when it fell 3.86%.
• Genmab A's Assets stood at $5.2 billion in 2023, then increased by 22.59% to $6.4 billion in 2024, then jumped by 100.7% to $12.9 billion in 2025, then slipped by 3.86% to $12.4 billion in 2026.
• The last three Assets figures came in at $12.4 billion (Q1 2026), $12.9 billion (Q4 2025), and $7.0 billion (Q3 2025), per Business Quant data.